Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
청소년의 mRNA-1273 SARS-CoV-2 백신 평가
Clinical Trial
[키워드] 95% CI
95% confidence interval
absolute difference
acute respiratory syndrome
Administered
Adolescent
Adults
Adverse reaction
age
assigned
Asymptomatic
coronavirus
coronavirus disease
criterion
development
Efficacy
fatigue
geometric mean titer
headache
healthy
immune response
incidence
Infection
injection
Injection-site pain
Moderna
mRNA-1273
mRNA-1273 vaccine
occurred
participant
Participants
phase 3 trial
Placebo
placebo-controlled trial
pseudovirus neutralizing antibody
Randomly
receive
reported
safety profile
SARS-CoV-2
Secondary objective
Serious Adverse Event
Serologic response
the placebo group
the vaccine
[DOI] 10.1056/NEJMoa2109522 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1056/NEJMoa2109522 PMC 바로가기 [Article Type] Clinical Trial